{"entity":{"id":"nct01594723","kind":"trial","name":"A Study of LY2784544 in Participants With Myeloproliferative Neoplasms","aka":[],"tldr":"A phase 2 trial of 120 mg LY2784544 in myeloproliferative neoplasms, run by Eli Lilly and Company, active and no longer recruiting.","summary":"A Study of LY2784544 in Participants With Myeloproliferative Neoplasms is a phase 2 interventional study registered as NCT01594723 by Eli Lilly and Company, with 110 participants enrolled, started 2012-05-22 and due to reach its primary completion in 2015-03-20. Interventions recorded: 120 mg LY2784544.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT01594723","url":"https://clinicaltrials.gov/study/NCT01594723"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["myeloproliferative-neoplasms"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["eli-lilly"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT01594723","phase":"2","setting":"A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms","sponsor":"Eli Lilly and Company","participation":[{"nct":"NCT01594723","source":"https://clinicaltrials.gov/study/NCT01594723","fetchedAt":"2026-10-07T16:52:30.512Z","studySha256":"fd9aa1b52e1354ca5b2522db67553851ec1e6f374d81584f033e6f5a1066844b","overallStatus":"ACTIVE_NOT_RECRUITING","lastUpdatePosted":"2026-06-23","leadSponsor":"Eli Lilly and Company","collaboratorCount":0,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":110,"enrolmentType":"ESTIMATED","siteCount":39,"recruitingSiteCount":0,"countries":["Australia","Austria","Canada","France","Germany","Italy","Spain","Sweden","United States"]}],"started":"2012-05-22","startedType":"actual","enrolled":110,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct01594723/","neighbours":{"cancer":[{"id":"myeloproliferative-neoplasms","kind":"cancer","name":"Myeloproliferative neoplasms (PV, ET, myelofibrosis)","route":"/cancers/myeloproliferative-neoplasms/"}],"company":[{"id":"eli-lilly","kind":"company","name":"Eli Lilly (incl. Loxo)","route":"/companies/eli-lilly/"}]}}